Home
Mail
News
Finance
Sports
Entertainment
Search
Mobile
More...
Yahoo Finance
Search
Skip to Navigation
Skip to Main Content
Skip to Related Content
Sign in
Mail
Sign in
to view your mail
Watchlists
My Portfolio
Markets
News
Videos
Yahoo Finance Plus
Screeners
Personal Finance
Crypto
Sectors
Contact Us
Advertisement
U.S. markets close in 1 hour 42 minutes
S&P 500
5,253.68
+5.19
(+0.10%)
Dow 30
39,786.64
+26.56
(+0.07%)
Nasdaq
16,381.75
-17.77
(-0.11%)
Russell 2000
2,123.79
+9.44
(+0.45%)
Crude Oil
83.01
+1.66
(+2.04%)
Gold
2,242.40
+29.70
(+1.34%)
Innovent Biologics, Inc. (IVBXF)
Other OTC - Other OTC Delayed Price. Currency in USD
Follow
4.8900
0.0000
(0.00%)
As of 09:57AM EDT. Market open.
Summary
Company Insights
Chart
Conversations
Statistics
Historical Data
Profile
Financials
Analysis
Options
Holders
Sustainability
Advertisement
Show
:
Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly
Upgrade to begin using 40 years of financial statements and get so much more.
Download
Income Statement
Expand All
All numbers in thousands
Upgrade to begin using 40 years of financial statements and get so much more.
Learn more
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
Total Revenue
5,018,313
4,556,380
4,269,729
3,843,819
Cost of Revenue
964,077
930,990
505,337
387,761
Gross Profit
4,054,236
3,625,390
3,764,392
3,456,058
Operating Expense
5,865,747
6,207,275
5,703,539
3,498,501
Operating Income
-1,811,511
-2,581,885
-1,939,147
-42,443
Net Non Operating Interest Income Expense
82,113
87,839
89,291
47,752
Pretax Income
-1,427,666
-2,170,469
-2,641,717
-858,713
Tax Provision
-59,715
8,801
87,038
139,708
Net Income Common Stockholders
-1,367,951
-2,179,270
-2,728,755
-998,421
Diluted NI Available to Com Stockholders
-1,367,951
-2,179,270
-2,728,755
-998,421
Basic EPS
-0.90
-1.46
-1.88
-0.74
Diluted EPS
-0.90
-1.46
-1.88
-0.74
Basic Average Shares
1,525,269
1,490,123
1,455,606
1,357,012
Diluted Average Shares
1,525,269
1,490,123
1,455,606
1,357,012
Total Expenses
6,829,824
7,138,265
6,208,876
3,886,262
Net Income from Continuing & Discontinued Operation
-1,367,951
-2,179,270
-2,728,755
-998,421
Normalized Income
-1,380,856
-2,183,141
-2,821,986
-1,020,753
Interest Income
102,700
189,537
151,755
116,102
Interest Expense
107,424
101,698
62,464
68,350
Net Interest Income
82,113
87,839
89,291
47,752
EBIT
-1,320,242
-2,068,771
-2,579,253
-790,363
EBITDA
-938,129
-1,749,349
-2,374,506
-704,736
Reconciled Cost of Revenue
964,077
930,990
505,337
387,761
Reconciled Depreciation
382,113
319,422
204,747
85,627
Net Income from Continuing Operation Net Minority Interest
-1,367,951
-2,179,270
-2,728,755
-998,421
Total Unusual Items Excluding Goodwill
2,627
5,162
124,308
29,776
Total Unusual Items
2,627
5,162
124,308
29,776
Normalized EBITDA
-951,597
-1,754,511
-2,498,814
-734,512
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
563.3262
1,291
31,077
7,444
Yahoo Finance Plus Essential access required.
Learn more
Advertisement
Advertisement
Data Disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Your Privacy Choices
About Our Ads
Sitemap
© 2024 Yahoo. All rights reserved.